Regeneron Reports First Quarter 2021 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
Regeneron (REGN) Tops Q1 EPS by 89c, Revenues Miss
May 6, 2021 6:35 AM EDTRegeneron (NASDAQ: REGN) reported Q1 EPS of $9.89, $0.89 better than the analyst estimate of $9.00. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.55 billion.
First quarter 2021 revenues increased 38% to $2.53 billion versus first quarter 2020; revenues excluding REGEN-COVTM(1) increased 20%First quarter 2021 EYLEA® U.S. net sales increased 15% to $1.35 billion versus first quarter 2020First quarter 2021 Dupixent® global net... More